Agile Therapeutics Inc expected to post a loss of $7.50 a share - Earnings Preview

Agile Therapeutics

08/05/2023 14:33

* Agile Therapeutics Inc  AGRX.OQ   AGRX.O  is expected
to show a
rise in quarterly revenue when it reports  results on May 11. 
    * The Princeton New Jersey-based  company is expected to
report  a
92.9% increase in revenue to $3.397 million from $1.76 million a
year ago, according to the estimate from one analyst, based on
Refinitiv data. 
    * ​Refinitiv's mean analyst estimate for Agile Therapeutics
Inc is
for a loss of $7.50 per share. 
    * The one available analyst rating on the shares is
"hold".  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Agile
Therapeutics Inc is $250​, above​ its last closing price
of $5.90. ​​​

This summary was machine generated May 8 at 13:33 GMT.  All
figures in US dollars  unless otherwise stated